Selling, General and Administrative: Selling, general and administrative expenses consist principally of promotion, marketing and research, stock-based compensation, employee costs, occupancy costs and other general administrative costs. Selling, general, and administrative expenses for the three months ended June 30, 2020, were $10.2 million, a decrease of $0.6 million, or 6%, compared to $10.8 million for the comparable period in 2019. Selling, general, and administrative expenses for the six months ended June 30, 2020, were $21.4 million, a decrease of $0.3 million, or 1%, compared to $21.7 million for the comparable period in 2019. These decreases were due to lower personnel expenses, lower ad sales commissions, reduced marketing and research, due in part to the termination of Nielsen ratings services for Cinelatino in the current quarter, offset in part by higher stock-based compensation and an increase in the bad debt reserve.
Depreciation and Amortization: Depreciation and amortization expense consists of depreciation of fixed assets and amortization of intangibles. Depreciation and amortization for the three months ended June 30, 2020, was $2.8 million, an increase of $0.2 million, or 9%, compared to $2.6 million for the comparable period in 2019, due to higher depreciation related to new assets placed into service for the replacement of equipment damaged by Hurricane Maria and equipment required as a result of the FCC spectrum repack and the amortization of intangibles recognized from the Snap Media acquisition. Depreciation and amortization for the six months ended June 30, 2020, was $5.9 million, a decrease of $0.7 million, or 11%, compared to $6.6 million for the comparable period in 2019, due to certain intangible assets that were fully amortized as of the first quarter of 2019.
Other Expenses: Other expenses include legal, financial advisory and other fees incurred in connection with acquisitions and corporate finance activities, including debt and equity financings. Other expenses for the three months ended June 30, 2020, were $0.0 million, a decrease of $0.4 million, compared to $0.4 million in the comparable period in 2019. Other expenses for the six months ended June 30, 2020, were $3.0 million, an increase of $2.4 million, compared to $0.7 million in the comparable period in 2019, due to the pursuit of strategic transactions.
Loss (Gain) from FCC repack and other: Loss (gain) from FCC spectrum repack and other primarily reflects reimbursements we have received from the FCC for equipment we have purchased as a result of the FCC mandated spectrum repack, and gain or loss from the sale of assets no longer utilized in the operations of the business. Loss from FCC spectrum repack and other for the three months ended June 30, 2020, was $0.2 million, an increased loss of $0.2 million as compared to the comparable period in 2019, due to the disposal of assets no longer utilized in the operations of the business during the current period. Loss from FCC spectrum repack and other for the six months ended June 30, 2020, was $0.2 million as compared to a gain of $1.5 million in the comparable period of 2019, due to reimbursements received in the prior year period from the FCC for equipment purchases required as a result of the FCC mandated spectrum repack.
Other Expenses
Interest Expense, net: Interest expense for the three and six months ended June 30, 2020, decreased $0.5 million, or 17% and $0.7 million, or 12%, respectively. These decreases were due to lower average interest rates due to the decline in LIBOR.
Loss on Equity Method Investments: Loss on equity method investments for the three months ended June 30, 2020, was $10.2 million, an increase of $0.4 million, compared to $9.8 million for the comparable period in 2019, due to higher losses at Canal 1. Loss on equity method investments for the six months ended June 30, 2020, was $17.2 million, which was flat with the comparable period in 2019 as the higher Canal 1 losses were offset by lower losses at Pantaya. Our pick up of losses at Pantaya declined due to the inception to date losses exceeding our funding commitment, and as a result, we have not recognized our share of the losses following the three month period ended March 31, 2019. For more information, see Note 5, “Equity Method Investments” of Notes to Condensed Consolidated Financial Statements, included elsewhere in this Quarterly Report.
Impairment of Equity Method Investment: At March 31, 2020, we deemed our investment in REMEZCLA to be impaired given the uncertainty caused by the COVID-19 pandemic and the associated going-concern risks. As a result, we recorded a non-cash impairment charge of $5.5 million reflecting the write-off of the full valuation of our investment in REMEZCLA. There were no additional equity method impairments recorded during the three months ended June 30, 2020. For more information, see Note 5, “Equity Method Investments” of Notes to Condensed Consolidated Financial Statements, included elsewhere in this Quarterly Report.